OOIR: Observatory of International Research

Papers

(The median citation count of Molecular Carcinogenesis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
MiR‐15a‐3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer	48
Breast cancer stem cells: A review of their characteristics and the agents that affect them	36
M2‐like tumor‐associated macrophages‐secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β‐catenin pathway in thyroid cancer	33
Tocilizumab inhibits IL‐8 and the proangiogenic potential of triple negative breast cancer cells	29
Inhibiting Wnt/beta‐catenin in CTNNB1‐mutated endometrial cancer	27
Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway	26
IL‐6 and IL‐8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor	25
Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell marker	25
A rohitukine derivative IIIM‐290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells	25
L‐fucose, a sugary regulator of antitumor immunity and immunotherapies	23
ALKBH5‐mediated m6A‐demethylation of USP1 regulated T‐cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B	22
TP53 mutations in head and neck cancer	22
Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer	22
CAF‐derived exosomes transmitted Gremlin‐1 promotes cancer progression and decreases the sensitivity of hepatoma cells to sorafenib	22
Focal adhesion kinase (FAK) inhibitor‐defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream mo	21
N⁶‐Methyladenosine (m⁶A) readers are dysregulated in renal cell carcinoma	20
The LncRNA FGD5‐AS1/miR‐497‐5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin‐resistance in laryngeal squamous cell carcinoma	20
Targeting mitochondrial metabolism for metastatic cancer therapy	20
MicroRNA‐141‐3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous sclerosis complex 1	19
FAP^high α‐SMA^low cancer‐associated fibroblast‐derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downs	19
LINC02381 aggravates breast cancer through the miR‐1271‐5p/FN1 axis to activate PI3K/AKT pathway	19
Anticancer activities of parthenolide in primary effusion lymphoma preclinical models	18
Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo	18
VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype	18
Autophagy modulates FSS‐induced epithelial–mesenchymal transition in hepatocellular carcinoma cells	17

RNA‐seq reveals novel cancer‐selective and disease subtype‐independent mechanistic targets of withaferin A in human breast cancer cells	17
Eugenol modulates genomic methylation and inactivates breast cancer‐associated fibroblasts through E2F1‐dependent downregulation of DNMT1/DNMT3A	17
Amateur antigen‐presenting cells in the tumor microenvironment	17
Hyperactivation of MEK/ERK pathway by Ca²⁺/calmodulin‐dependent protein kinase kinase 2 promotes cellular proliferation by activating cyclin‐dependent kinases and minichromosome maintenance	17
Immunomodulatory role of thrombin in cancer progression	16
Computational modeling of malignant ascites reveals CCL5–SDC4 interaction in the immune microenvironment of ovarian cancer	15
DDIT4 promotes malignancy of head and neck squamous cell carcinoma	15
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres	15
FAM129B‐dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells	14
In vivo CRISPR–Cas9 knockout screening using quantitative PCR identifies thymosin beta‐4 X‐linked that promotes diffuse‐type gastric cancer metastasis	14
Pharmacologic inhibition of ataxia telangiectasia and Rad3‐related (ATR) in the treatment of head and neck squamous cell carcinoma	14
Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1‐mediated EMT	14
USP39 mediates p21‐dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis	14
H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4	14
Periostin secreted from podoplanin‐positive cancer‐associated fibroblasts promotes metastasis of gastric cancer by regulating cancer stem cells via AKT and YAP signaling pathway	13
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway	13
CMTM4 regulates epithelial–mesenchymal transition and PD‐L1 expression in head and neck squamous cell carcinoma	13
HPV‐16/18 E6‐induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1	13
Associations of genetically predicted circulating insulin‐like growth factor‐1 and insulin‐like growth factor binding protein‐3 with bladder cancer risk	13
Effects of radiation on tumor vasculature	12
PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia	12
miR‐506‐loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple‐negative breast cancer aggressiveness	12
Pharmacologic approaches to amino acid depletion for cancer therapy	12
Cucurbitacin I (JSI‐124)‐dependent inhibition of STAT3 permanently suppresses the pro‐carcinogenic effects of active breast cancer‐associated fibroblasts	12
Tumor‐derived exosomes: Key players in non‐small cell lung cancer metastasis and their implication for targeted therapy	12
HIF‐1α‐regulated stanniocalcin‐1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway	12
YAP/TEAD4‐induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma	12
Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma	12
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity	12
Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney rena	12
Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer	11
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR)	11
Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression	10
Circ‐E‐Cad encodes a protein that promotes the proliferation and migration of gastric cancer via the TGF‐β/Smad/C‐E‐Cad/PI3K/AKT pathway	10
HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells	10
Quercetin attenuates the proliferation of arsenic‐related lung cancer cells via a caspase‐dependent DNA damage signaling	10
Alternative splicing: An important regulatory mechanism in colorectal carcinoma	10
Development and validation of 3‐CpG methylation prognostic signature based on different survival indicators for colorectal cancer	10
DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice	10
PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β‐catenin pathway	9
LINC00662 modulates cervical cancer cell proliferation, invasion, and apoptosis via sponging miR‐103a‐3p and upregulating PDK4	9
Twist1 is required for the development of UVB‐induced squamous cell carcinoma	9
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells	9
Enrichment of progenitor cells by 2‐acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo	9
Mefloquine induces ER stress and apoptosis in BRAFi‐resistant A375‐BRAF^V600E/NRAS^Q61K malignant melanoma cells targeting intracranial tumors in a bioluminescent murine model	9
Methylseleninic acid overcomes programmed death‐ligand 1‐mediated resistance of prostate cancer and lung cancer	9
SCR7, an inhibitor of NHEJ can sensitize tumor cells to ionization radiation	9
Common tumor‐suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells	9
CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas	9
Suppression of beta 2 adrenergic receptor actions prevent UVB mediated cutaneous squamous cell tumorigenesis through inhibition of VEGF‐A induced angiogenesis	9

Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration‐resistant prostate cancer	9
CircSPAG16 suppresses cadmium‐induced transformation of human bronchial epithelial cells by decoying PIP5K1α to inactivate Akt	8
Downregulation of STK25 promotes autophagy via the Janus kinase 2/signal transducer and activator of transcription 3 pathway in colorectal cancer	8
Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma	8
A review of Plks: Thinking outside the (polo) box	8
Toll‐like receptor‐4 deficiency inhibits ultraviolet radiation‐induced tumor development by modulation of immune and inflammatory responses	8
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma	8
KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation	8
Plasma cell‐free DNA methylome profiling in pre‐ and post‐surgery oral cavity squamous cell carcinoma	8
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway	8
PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation	7
Nutlin‐3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation	7
MicroRNA‐519d‐3p antagonizes osteosarcoma resistance against cisplatin by targeting PD‐L1	7
Identification of a novel TNRC18‐RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML‐RARA	7
Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma	7
Role of hemoglobin alpha and hemoglobin beta in non‐small‐cell lung cancer based on bioinformatics analysis	7
Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway	7
Monocarboxylate transporter 1 is a novel target for breast cancer stem like‐cell inhibition by diallyl trisulfide	7
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF‐β1/pERK signaling pathway	7
Histone demethylase JMJD1A in cancer progression and therapeutic resistance	7
The FoxQ1 transcription factor is a novel regulator of electron transport chain complex I subunits in human breast cancer cells	7
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors	7
FTO promotes the progression of cervical cancer by regulating the N6‐methyladenosine modification of ZEB1 and Myc	7
m7G‐related genes—NCBP2 and EIF4E3 determine immune contexture in head and neck squamous cell carcinoma by regulating CCL4/CCL5 expression	7
A novel oncogene trigger transposable element derived‐1 promotes oral squamous cell carcinoma progression via evoking immune inhibition	7
Transcriptional repression of E‐cadherin in nickel‐exposed lung epithelial cells mediated by loss of Sp1 binding at the promoter	7
Low expression of lncRNA SBF2‐AS1 regulates the miR‐302b‐3p/TGFBR2 axis, promoting metastasis in laryngeal cancer	7
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline‐deficient l‐amino acid‐defined diet prevents hepatocarcinogenesis in mice	7
UHRF1 plays an oncogenic role in small cell lung cancer	6
NUAK family kinase 2 is a novel therapeutic target for prostate cancer	6
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway	6
Characterization of stage‐specific tumor progression in TMPRSS2‐ERG (fusion)‐driven and non‐fusion‐driven prostate cancer in GEM models	6
Review: PD‐L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer	6
Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells	6
Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation	6
Doublecortin‐like kinase 1 is a therapeutic target in squamous cell carcinoma	6
Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF‐1α/ATG5 axis	6
Long noncoding RNA TFAP2A‐AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR‐1297 and regulating TFAP2A expression	6
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling	6
SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression	6
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation	6
LKB1 loss promotes colorectal cancer cell metastasis through regulating TNIK expression and actin cytoskeleton remodeling	6
CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple‐negative breast cancer by targeting miR‐761/DACT2 signaling axis	6
Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5	6
Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells	6
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism	6
Silencing of UAP1L1 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma	6
Hypoxic nasopharyngeal carcinoma‐derived exosomal miR‐455 increases vascular permeability by targeting ZO‐1 to promote metastasis	6
A comprehensive evaluation of serum tRF‐29‐R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer	6
The action and resistance mechanisms of Lenvatinib in liver cancer	6
Genetic variants in DDO and PEX5L in peroxisome‐related pathways predict non‐small cell lung cancer survival	6
RAS induced senescence of skin keratinocytes is mediated through Rho‐associated protein kinase (ROCK)	6
USF1‐mediated ALKBH5 stabilizes FLII mRNA in an m6A‐YTHDF2‐dependent manner to repress glycolytic activity in prostate adenocarcinoma	5
E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcription	5
FOXD3 suppresses epithelial–mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma	5
Crucial role of glucosylceramide synthase in the regulation of stem cell‐like cancer cells in B16F10 murine melanoma	5
CircTCF25 serves as a sponge for miR‐206 to support proliferation, migration, and invasion of glioma via the Jak2/p‐Stat3/CypB axis	5
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling	5
Metabolic response to radiation therapy in cancer	5
m⁶A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m⁶A‐EGFR/STAT3 axis and EMT	5
Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype	5
Mitochondria‐targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species	5
Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC	5
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition	5
HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z1	5
Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer	5
KLF14/miR‐1283/TFAP2C axis inhibits HER2‐positive breast cancer progression via declining tumor cell proliferation	5
Inhibition of endogenous hydrogen sulfide production suppresses the growth of nasopharyngeal carcinoma cells	5
Angiopoietin‐like protein 3 promotes colorectal cancer progression and liver metastasis partly via the mitogen‐activated protein kinase 14 pathway	5
p21‐activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1	5
An integrative analysis reveals the prognostic value and potential functions of PSMD11 in hepatocellular carcinoma	5
Germline MC1R variants and frequency of somatic BRAF, NRAS, and TERT mutations in melanoma: Literature review and meta‐analysis	5
Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells	5
The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance	5
Rapalogs induce non‐apoptotic, autophagy‐dependent cell death in HPV‐negative TP53 mutant head and neck squamous cell carcinoma	5
ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β‐catenin signaling pathway	4
Best practices in surgical and nonsurgical management of head and neck Merkel cell carcinoma: An update	4
A novel m7G regulator‐based methylation patterns in head and neck squamous cell carcinoma	4
Functional characterization and clinical significance of super‐enhancers in lung adenocarcinoma	4
SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway	4

KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma	4
Stage‐specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis	4
Transcriptional activation of S100A2 expression by HIF‐1α via binding to the hypomethylated hypoxia response elements in HCC cells	4
Role of RNA modifications in carcinogenesis and carcinogen damage response	4
Independent effects of Src kinase and podoplanin on anchorage independent cell growth and migration	4
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases	4
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder	4
Transfer of miR‐4755‐5p through extracellular vesicles and particles induces decitabine resistance in recipient cells by targeting CDKN2B	4
Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1⁺INHBA⁺CAF as drivers of colorectal cancer progression	4
Circular RNA ACACA negatively regulated p53‐modulated mevalonate pathway to promote colorectal tumorigenesis via regulating miR‐193a/b‐3p/HDAC3 axis	4
Deletion of arylamine N‐acetyltransferase 1 in MDA‐MB‐231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis	4
Knockdown of UBE2I inhibits tumorigenesis and enhances chemosensitivity of cholangiocarcinoma via modulating p27kip1 nuclear export	4
Comprehensive DNA methylation profiling of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients	4
Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients	4
Novel MLL/KMT2A‐MON2 fusion in a child with therapy‐related acute myeloid leukemia after treatment for acute promyelocytic leukemia	4
USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle	4
Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mTOR pathway in hepatocellular carcinoma	4
Associations of mitochondrial DNA copy number with incident risks of gastrointestinal cancers: A prospective case–cohort study	4
PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming	4
Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk	4
Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing	4
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c‐Myc signaling	4
Activin A/ACVR2A axis inhibits epithelial‐to‐mesenchymal transition in colon cancer by activating SMAD2	4
Gender‐based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum‐fermented rice bran diet against inflammation‐associated colon tumorigenesis	4
Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS‐mutant human lung cancer cells	4
Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer	4
Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma	4
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas	4
Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer	4
Inhibition of Wnt/β‐catenin pathway overcomes therapeutic resistance to abiraterone in castration‐resistant prostate cancer	4
A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells	3
Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma	3
LATS‐regulated nuclear‐cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial–mesenchymal transition	3
The relationship of nutritional status with anticancer immunity and its prognostic value for head and neck cancer	3
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype	3
A novel hypoxia‐stimulated lncRNA HIF1A‐AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription	3
Proanthocyanidins mitigate bile acid‐induced changes in GSTT2 levels in a panel of racially diverse patient‐derived primary esophageal cell cultures	3
The Parkinson's disease‐associated protein α‐synuclein inhibits hepatoma by exosome delivery	3
ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression	3
Prognostic signatures and potential pathogenesis of eRNAs‐related genes in colon adenocarcinoma	3
Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype	3
ARHGEF40 promotes non‐small cell lung cancer proliferation and invasion via the AKT‐Wnt axis by binding to RhoA	3
circRNA TATA‐box binding protein associated factor 15 acts as an oncogene to facilitate bladder cancer progression through targeting miR‐502‐5p/high mobility group box 3	3
PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway	3
G2 and S phase‐expressed‐1 induces chromosomal instability in esophageal squamous cell carcinoma cells and inhibits cell apoptosis through ROS/JNK signaling	3
Withaferin A inhibits breast cancer‐induced osteoclast differentiation	3
Colorectal cancer risk susceptibility loci in a Swedish population	3
Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer	3
IL‐8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR‐146a mediated mechanism	3
Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer	3
PLIC11 drives lung cancer progression through regulating the YY1/PIWIL4 axis	3
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies	3
GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma	3
SUMO1 degrader induces ER stress and ROS accumulation through deSUMOylation of TCF4 and inhibition of its transcription of StarD7 in colon cancer	3
Natural killer cells suppress human cutaneous squamous cell carcinoma cancer cell survival and tumor growth	3
Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell‐like properties and phosphoinositide 3‐kinas	3
Cathepsin V is correlated with the prognosis and tumor microenvironment in liver cancer	3
Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase	3
RFC5, regulated by circ_0038985/miR‐3614‐5p, functions as an oncogene in the progression of colorectal cancer	3
Insulin‐like growth factor‐2 mRNA‐binding protein 3 promotes cell migration, invasion, and epithelial−mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E‐box‐	3
Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV‐related hepatocellular carcinoma survival	3
lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer	3
Effects of genetic polymorphisms in INTS10 and their interaction with environmental factors on progression from persistent HBV infection to hepatocellular carcinoma	3
A potential signaling axis between RON kinase receptor and hypoxia‐inducible factor‐1 alpha in pancreatic cancer	3
IL‐17 induces non‐small cell lung cancer metastasis via GCN5‐dependent SOX4 acetylation enhancing MMP9 gene transcription and expression	3
Phosphoproteomics of extracellular vesicles integrated with multiomics analysis reveals novel kinase networks for lung cancer	3
MCPIP1 expression positively correlates with melanoma‐specific survival of patients, and its overexpression affects vital intracellular pathways of human melanoma cells	3
Genetic susceptibility to prostate cancer in Taiwan: A genome‐wide association study	3
Diallyl trisulfide inhibits gastric cancer stem cell properties through ΔNp63/sonic hedgehog pathway	3
Metabolomics‐based classification reveals subtypes of hepatocellular carcinoma	3
An integrated analysis of Dynamin 1 Like: A new potential prognostic indicator in hepatocellular carcinoma	2
PARP5B is required for nonhomologous end joining during tumorigenesis in vivo	2
Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer	2
Cip2a induces arginine biosynthesis and promotes tumor progression in non‐small cell lung cancer	2
Latrophilin‐3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis	2
Venetoclax overcomes resistance to all‐trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion	2
Prevention of mammary carcinogenesis in MMTV‐neu mice by targeting RLIP	2
LncRNA ENST00000370438 promotes cell proliferation by upregulating DHCR24 in breast cancer	2
HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells	2
Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C	2
Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation	2
CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1	2
Urinary parabens and breast cancer risk: Modification by LINE‐1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status	2
Insulin‐like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high‐grade serous carcinoma from fallopian tube epithelial cells: Disse	2
The HDAC2–MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c‐Myc and cyclin D1	2
SH3 domain‐binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β‐catenin and Raf/ERK1/2 signaling pathways	2
USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2	2
Circ_0001589/miR‐1248/HMGB1 axis enhances EMT‐mediated metastasis and cisplatin resistance in cervical cancer	2
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells	2
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype	2
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer	2
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors	2
BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial‐mesenchymal transition and hepatic stellate cells	2
KRAS mutations upregulate Runx1 to promote occurrence of head and neck squamous cell carcinoma	2
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors	2